1st Quarter - Report

BIOCOM for BIOCOM

Period 1st Quarter 2016 Filed Apr 20, 2016 Signed by Laure Fabrega

Official filing
Firm
BIOCOM
Client
BIOCOM
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Asked for increased NIH funding.

LobbyistCovered position, as disclosed
LAURE FABREGA CLARK —

Contacted: Natl Institutes of Health (NIH); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Health Issues HCR

Asked Congress to prioritize the use of telehealth and remote patient monitoring technologies. Organized a Precision Medicine Fly-In to educate regulators and legislators about precision medicine. Urged the Senate HELP Committee to provide mandatory funding for the NIH in its biomedical initiative. Raised concerns regarding CMS' Part B Demo.

LobbyistCovered position, as disclosed
LAURE FABREGA CLARK —

Contacted: Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.